McEachern; Donna

Patent Applications and Registrations

Patent applications and USPTO patent grants for McEachern; Donna.The latest application filed is for "small molecule mdm2 protein degraders".

Company Profile

6.16.18

McEachern; Donna - Ann Arbor MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
BET bromodomain protein degraders with cleavable linkers Grant 11,267,822 - Wang , et al. March 8, 2	2022-03-08
Small Molecule Mdm2 Protein Degraders App 20210309666 - Wang; Shaomeng ; et al.	2021-10-07
Fused 1,4-oxazepines As Bet Protein Degraders App 20210284657 - Wang; Shaomeng ; et al.	2021-09-16
Small molecule MDM2 protein degraders Grant 11,046,703 - Wang , et al. June 29, 2	2021-06-29
5,6-dihydro-1 1h-indolo{2,3-b}quinolin- 11-one Compounds As Alk Inhibitors App 20210087188 - CHEN; Jianyong ; et al.	2021-03-25
5,6-dihydro-11H-indolo[2,3-B]quinolin-11-ones as alk inhibitors Grant 10,781,208 - Chen , et al. Sept	2020-09-22
BET Bromodomain Protein Degraders with Cleavable Linkers App 20200277305 - Wang; Shaomeng ; et al.	2020-09-03
Small Molecule Mdm2 Protein Degraders App 20200109149 - Wang; Shaomeng ; et al.	2020-04-09
5,6-dihydro-11h-indolo[2,3-b]quinolin-11-ones As Alk Inhibitors App 20190315741 - Chen; Jianyong ; et al.	2019-10-17
BET bromodomain inhibitors and therapeutic methods using the same Grant 10,391,175 - Wang , et al. A	2019-08-27
9H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitors Grant 10,253,044 - Wang , et al.	2019-04-09
Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors Grant 9,783,539 - Chen , et al. October 10, 2	2017-10-10
Bet Bromodomain Inhibitors And Therapeutic Methods Using The Same App 20170281773 - Wang; Shaomeng ; et al.	2017-10-05
MDM2 inhibitors and therapeutic methods using the same Grant 9,745,314 - Wang , et al. August 29, 2	2017-08-29
9h-pyrimido [4,5-b]indoles And Related Analogs As Bet Bromodomain Inhibitors App 20170210761 - Wang; Shaomeng ; et al.	2017-07-27
BET bromodomain inhibitors and therapeutic methods using the same Grant 9,675,697 - Wang , et al. June 13, 2	2017-06-13
Indoloquinolone Compounds As Anaplastic Lymphoma Kinase (alk) Inhibitors App 20170066761 - CHEN; Jianyong ; et al.	2017-03-09
9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors Grant 9,580,430 - Wang , et al. February 28, 2	2017-02-28
Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same Grant 9,403,856 - Wang , et al. August 2, 2	2016-08-02
Bcl-2/bcl-xl Inhibitors And Therapeutic Methods Using The Same App 20150336994 - Wang; Shaomeng ; et al.	2015-11-26
Mdm2 Inhibitors And Therapeutic Methods Using The Same App 20150299211 - Wang; Shaomeng ; et al.	2015-10-22
9h-pyrimido[4,5-b]indoles And Related Analogs As Bet Bromodomain Inhibitors App 20150246923 - Wang; Shaomeng ; et al.	2015-09-03
BCL-2/BCL-XL inhibitors and therapeutic methods using the same Grant 9,096,625 - Wang , et al. August 4, 2	2015-08-04
Spiro-oxindole MDM2 antagonists Grant 9,079,913 - Wang , et al. July 14, 2	2015-07-14
Spiro-oxindole Mdm2 Antagonists App 20140378680 - Wang; Shaomeng ; et al.	2014-12-25
Bivalent inhibitors of IAP proteins and therapeutic methods using the same Grant 8,883,771 - Wang , et al. November 11, 2	2014-11-11
Spiro-oxindole MDM2 antagonists Grant 8,877,796 - Wang , et al. November 4, 2	2014-11-04
Bet Bromodomain Inhibitors And Therapeutic Methods Using The Same App 20140256706 - Wang; Shaomeng ; et al.	2014-09-11
Bcl-2/bcl-xl Inhibitors And Therapeutic Methods Using The Same App 20140199234 - Wang; Shaomeng ; et al.	2014-07-17
Bivalent Inhibitors Of Iap Proteins And Therapeutic Methods Using The Same App 20140057924 - Wang; Shaomeng ; et al.	2014-02-27
Spiro-oxindole Mdm2 Antagonists App 20130296303 - Wang; Shaomeng ; et al.	2013-11-07
Spiro-oxindole MDM2 antagonists Grant 8,518,984 - Wang , et al. August 27, 2	2013-08-27
Spiro-oxindole Mdm2 Antagonists App 20110112052 - Wang; Shaomeng ; et al.	2011-05-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.